Tiziana Life Sciences has pointed to increased Big Pharma interest in the IL-6 pathway as justification for its decision to spin out its own candidate into a separate company. In September, Tiziana ...
Vaccine immunotherapy targeting interleukin 6 (IL-6) has shown promising results in the treatment of inflammatory osteoarthritis of the knee, according to a phase 1 double-blind controlled study.
The last time I spoke about Tourmaline Bio, Inc. (TRML), it was with respect to a Seeking Alpha article entitled "Tourmaline Bio: TRANQUILITY Study Data Lends Credibility For IL-6 Inhibition." With ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Some patients are suboptimal responders to anti-VEGF ...
A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...
High levels of the protein interleukin 6 (IL-6) in the aqueous fluid of the eye may be a powerful biomarker for evaluating the severity of diabetic eye disease and could help identify patients at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results